DNA G-quadruplex binders: a patent review

Bibliography

• Palchaudhuri R, Hergenrother PJ. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr Opin Biotechnol 2007;18(6):497-503
   PubMed Web of Science ®Google Scholar
• Hurley LH. DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2002;2(3):188-200
   PubMed Web of Science ®Google Scholar
• Choi J, Majima T. Conformational changes of non-B DNA. Chem Soc Rev 2011;40(12):5893-909
   Google Scholar
• Gellert M, Lipsett MN, Davies DR. Helix formation by guanylic acid. Proc Natl Acad Sci USA 1962;48:2013-18
   PubMed Web of Science ®Google Scholar
• Collie GW, Sparapani S, Parkinson GN, et al. Structural basis of telomeric RNA quadruplex–acridine ligand recognition. J Am Chem Soc 2011;133(8):2721-8
   Google Scholar
• Todd AK, Johnston M, Neidle S. Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res 2005;33(9):2901-7
   PubMed Web of Science ®Google Scholar
• Huppert JL, Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res 2005;33(9):2908-16
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Hurley LH, Neidle S. Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov 2011;10(4):261-75
   PubMed Web of Science ®Google Scholar
• Lopes J, Piazza A, Bermejo R, et al. G-quadruplex-induced instability during leading-strand replication. EMBO J 2011;30(19):4033-46
   PubMed Web of Science ®Google Scholar
• Paeschke K, Capra JA, Zakian VA. DNA replication through G-quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell 2011;145(5):678-91
   PubMed Web of Science ®Google Scholar
• Gonzalez V, Hurley LH. The c-MYC NHE III(1): function and regulation. Annu Rev Pharmacol Toxicol 2010;50:111-29
   PubMed Web of Science ®Google Scholar
• Grandin N, Charbonneau M. Protection against chromosome degradation at the telomeres. Biochimie 2008;90(1):41-59
   Google Scholar
• Gomez DE, Armando RG, Farina HG, et al. Telomere structure and telomerase in health and disease (review). Int J Oncol 2012;41(5):1561-9
   Web of Science ®Google Scholar
• Tumpel S, Rudolph KL. The role of telomere shortening in somatic stem cells and tissue aging: lessons from telomerase model systems. Ann N Y Acad Sci 2012;1266:28-39
   PubMed Web of Science ®Google Scholar
• Blackburn EH. Structure and function of telomeres. Nature 1991;350(6319):569-73
   PubMed Web of Science ®Google Scholar
• Paeschke K, McDonald KR, Zakian VA. Telomeres: structures in need of unwinding. FEBS Lett 2010;584(17):3760-72
   Google Scholar
• Kelland L. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin Cancer Res 2007;13(17):4960-3
   PubMed Web of Science ®Google Scholar
• De Cian A, Lacroix L, Douarre C, et al. Targeting telomeres and telomerase. Biochimie 2008;90(1):131-55
   Google Scholar
• Longhese MP, Anbalagan S, Martina M, et al. The role of shelterin in maintaining telomere integrity. Front Biosci 2012;17:1715-28
   Google Scholar
• Drygin D, Siddiqui-Jain A, O'Brien S, et al. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res 2009;69(19):7653-61
   PubMed Web of Science ®Google Scholar
• Rickards B, Flint SJ, Cole MD, et al. Nucleolin is required for RNA polymerase I transcription in vivo. Mol Cell Biol 2007;27(3):937-48
   PubMedGoogle Scholar
• Hanakahi LA, Sun H, Maizels N. High affinity interactions of nucleolin with G-G-paired rDNA. J Biol Chem 1999;274(22):15908-12
   Google Scholar
• Wu Y, Brosh RM Jr. G-quadruplex nucleic acids and human disease. FEBS J 2010;277(17):3470-88
   PubMed Web of Science ®Google Scholar
• Baral A, Kumar P, Pathak R, et al. Emerging trends in G-quadruplex biology - role in epigenetic and evolutionary events. Mol Biosyst 2013;9(7):1568-75
   Google Scholar
• De S, Michor F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat Struct Mol Biol 2011;18(8):950-5
   PubMed Web of Science ®Google Scholar
• Paeschke K, Bochman ML, Garcia PD, et al. Pif1 family helicases suppress genome instability at G-quadruplex motifs. Nature 2013;497(7450):458-62
   PubMed Web of Science ®Google Scholar
• Huppert JL, Bugaut A, Kumari S, et al. G-quadruplexes: the beginning and end of UTRs. Nucleic Acids Res 2008;36(19):6260-8
   PubMed Web of Science ®Google Scholar
• Xu Y, Suzuki Y, Ito K, et al. Telomeric repeat-containing RNA structure in living cells. Proc Natl Acad Sci USA 2010;107(33):14579-84
   Google Scholar
• Millevoi S, Moine H, Vagner S. G-quadruplexes in RNA biology. Wiley Interdiscip Rev RNA 2012;3(4):495-507
   Google Scholar
• Xu Y. Human telomere RNA: a potential target for ligand recognition. Curr Pharm Des 2012;18(14):2096-101
   Google Scholar
• Ou TM, Lu YJ, Tan JH, et al. G-quadruplexes: targets in anticancer drug design. ChemMedChem 2008;3(5):690-713
   Google Scholar
• Biffi G, Tannahill D, McCafferty J, et al. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat Chem 2013;5(3):182-6
   PubMed Web of Science ®Google Scholar
• Lam EY, Beraldi D, Tannahill D, et al. G-quadruplex structures are stable and detectable in human genomic DNA. Nat Commun 2013;4:1796
   PubMed Web of Science ®Google Scholar
• Whitten JP, Schwaebe M, Siddiqui-Jain A, et al. Pharmaceutical composition useful for the treatment of cell proliferative disorders e.g., cancer comprises quinobenzoxazine analogs. WO2006078317A1; 2006
   Google Scholar
• Hurley LH, Guzman M. Combination cancer chemotherapy. WO2007137000; 2007
   Google Scholar
• Available from: www.clinicaltrials.gov
   Google Scholar
• Bianco A, Franceschin M, Alvino A, et al. Preparation of water-soluble coronene derivatives which inhibit human telomerase via induction of G-quadruplex structures and their use as anticancer agents. WO2008126123; 2008
   Google Scholar
• Gunaratnam M, Cuenca F, Neidle S. Preparation of naphthalene diimide compounds for cancer treatment. WO2009068916; 2009
   Google Scholar
• Balasubramanian S, Bejugam M. New 10H-benzo(G)pteridine-2,4-dione compound useful for treating e.g., cancer, psoriasis, bone diseases, atherosclerosis, stenosis and restenosis. WO2008114009-A1; 2008
   Google Scholar
• Huang H. Anthraquinone-based compound, the synthesis processes and the application thereof. US2012316234A1; 2012
   Google Scholar
• Huang Z, Gu L, Lu Y, et al. New aliphatic amino substituted dimethylindole quinoline derivative for preparing antineoplastic drug, e.g., tablet, pill, capsule, injection, suspending agent or emulsion. CN101250187; 2008
   Google Scholar
• Gu L, Huang Z, Li Z, et al. New benzofuran quinoline peptide derivatives, useful for the preparation of anticancer drugs, preferably lung cancer drugs. CN102516355A; 2012
   Google Scholar
• Gu L, Huang Z, Li Z, et al. New difatty amino substituted indoloquinoline derivative used for preparing antitumor medicine. CN102206222A; 2011
   Google Scholar
• Gu L, Huang Z, Li Z, et al. New substituted quinazoline derivatives, useful for preparing anti-cancer drug and inhibiting various cancer cell strains. CN101967127A; 2011
   Google Scholar
• Huang Z, Gu L, He J, et al. Preparation method and antitumor application of 2-phenyl quinazoline derivative. CN103012291; 2013
   Google Scholar
• Chang T, Wang Z-F, Cho C-C, et al. Pharmaceutical composition for treating cancer and applications. US20130005720; 2013
   Google Scholar
• Wang ZF, Chang TC. Molecular engineering of G-quadruplex ligands based on solvent effect of polyethylene glycol. Nucleic Acids Res 2012;40(17):8711-20
   Google Scholar
• Huang Z, Gu L, Tan J, et al. New carbazole derivative useful for preparing anticancer drug and for resisting breast cancer or lung cancer. CN102491972A; 2012
   Google Scholar
• Burger AM. G-quadruplex ligand telomere targeting agents as stem cell directed treatments. US20080279961A1; 2008
   Google Scholar
• Wei C, Wang L, Wen Y. Preparation of phenanthroline derivatives as antitumor agents. CN101967144; 2011
   Google Scholar
• Wei C, Wang J, Liu J. Imidazolo[4,5-f]-1,10-phenanthroline derivative with antitumor activity and preparation. CN102276607; 2011
   Google Scholar
• Huang Z, Gu L, Zhang W, et al. New 9-fat amino substituted berberine derivate for used in preparing anti-cancer medicine. CN101050213A; 2008
   Google Scholar
• Huang Z, Gu L, Ma Y, et al. New 9-N-substituted berberine derivative for preparing anticancer drugs. CN101255158; 2008
   Google Scholar
• Gu L, Huang S, Huang Z, et al. New benzacridine compound for preparing medicine that is utilized for curing cancer. CN102351870A; 2012
   Google Scholar
• Jin Y, Zhang Q, Wang W. Method for preparation of Aloeemodin derivative and its application as antitumor agents. CN102838530; 2012
   Google Scholar
• Gu L, Huang Z, Huang S, et al. New coumarin derivative used for manufacturing drug for treating cancer, has reduced toxicity. CN101985449; 2011
   Google Scholar
• Shin-ya K, Wierzba K, Matsuo K, et al. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J Am Chem Soc 2001;123(6):1262-3
   PubMed Web of Science ®Google Scholar
• Monchaud D, Granzhan A, Saettel N, et al. “One ring to bind them all”-part I: the efficiency of the macrocyclic scaffold for g-quadruplex DNA recognition. J Nucleic Acids 2010;2010, p.19
   Google Scholar
• Granzhan A, Monchaud D, Saettel N, et al. “One Ring to Bind Them All”-Part II: identification of Promising G-Quadruplex Ligands by Screening of Cyclophane-Type Macrocycles. J Nucleic Acids 2010;2010, p.11
   Google Scholar
• Nagasawa K, Shinya K, Takagi M, et al. Novel macrocyclic hepta oxazole structure-containing compound useful for treating cancer, has amino group in side chain. WO2009157505; 2009
   Google Scholar
• Lavoie EJ, Rice JE. Therapeutic compounds for treatment of cancer. WO2009018551; 2009
   Google Scholar
• Lavoie EJ, Rice JE, Liu LF. Preparation of cyclic polyazoles as G-quadruplex DNA stabilizers and antiproliferative agents. WO2007127173; 2007
   Google Scholar
• Lavoie EJ, Rice JE, Mavurapu S. Preparation of cyclic poly-oxazoles as G-quadruplex DNA stabilizers and anti-proliferative agents. WO2009018549; 2009
   Google Scholar
• Lavoie EJ, Rice JE, Rzuczek SG, et al. New heterocyclic compound useful in preparation of pharmaceuticals for preventing or treating cancer e.g., acute leukemia, or cancer of breast, pancreas, ovary, colon, head or neck. WO2011057126; 2011
   Google Scholar
• Balasubramanian S, Jantos K, Ladame S. Preparation of heteroaromatic-based peptide macrocycles as G-quadruplex ligands. WO2008009942; 2008
   Google Scholar
• Tang Y, Xu X, Li Q, et al. Application of oxyacanthine and its analogs in inhibiting eukaryotic tumor cell proliferation. CN101371840; 2009
   Google Scholar
• Tang Y, Xu X, Li Q, et al. Application of dibenzyl isoquinolin-like alkaloids in preventing and/or treating neoplasm. CN101371839; 2009
   Google Scholar
• Gu L, Huang Z, Tan J, et al. New quinazolinone derivative used in preparing anti-cancer drugs, prepared by processing ring closing reaction to 2-aminobenzoic acid, processing condensation reaction with benzaldehyde, and reacting with amine compound. CN101857595A; 2010
   Google Scholar
• Huang Z, Gu L, Tan J, et al. New dialiphatic amino substituted thiazolone derivative, useful for preparing anticancer medicament, e.g., troche, pill, capsule, injection, suspension or emulsion. CN101250189; 2008
   Google Scholar
• Henary M, Wilson WD. Carbocyanines for G-quadruplex DNA stabilization and telomerase inhibition. WO2013012886; 2013
   Google Scholar
• Moses JE, Neidle S, Moorhouse AD, et al. New ureylene derivatives useful in the treatment of e.g., central nervous system disease, inflammation, urological disease, developmental disorder, cancer, metabolic disease, viral, bacterial and endocrinological diseases. WO2008122667A2; 2008
   Google Scholar
• Neidle S, Moses JE, Moorhouse AD, et al. Preparation of triazole derivatives as cell proliferation inhibitors. WO2008062235; 2008
   Google Scholar
• Nguyen C-H, Rouchon Dagois M, Guedin-Beaurepaire A, et al. Preparation of poly-heteroaryl derivatives for the treatment of cancer and infectious diseases and as quadruplex-specific DNA probes. EP2010049915; 2010
   Google Scholar
• Tang Y, Xu X, Li Q, et al. Medical application of Fritillaria isosteroidal alkaloids. CN101352445; 2009
   Google Scholar
• Chang T-C, Cho C-C, Chang C-C, et al. Fluorescent carbazole compounds for cancer diagnosis. EP2319842; 2011
   Google Scholar
• Tang B, Dong Y, Haeussler M, et al. Detecting G-quadruplex formation, DNA, or protein and protein levels in a biological sample comprises contacting the biological sample with the water-soluble conjugated polyene compound and detecting luminescence. US2010009362A1; 2010
   Google Scholar
• Tang Y, Xiang J, Xu G, et al. Use of cyanine dye for detecting G-quadruplex structure DNA, which has advantages of simpleness, convenience and relatively low price. CN101587066A; 2008
   Google Scholar
• Tang Y, Yang Q, Xiang J, et al. Application of supramolecular ordered substance in detecting G-quadruplexes structure of DNA. CN101587070; 2009
   Google Scholar
• Huang Z, Gu L, Tan J, et al. Difunctional probe, its preparation method and application for detecting g-four-chain structure in DNA. CN102719238; 2012
   Google Scholar
• Huang Z, Gu L, Tan J, et al. Preparation of quinolinium dyes for detecting specific secondary structure of DNA. CN102408741; 2012
   Google Scholar
• Georgiades SN, Abd Karim NH, Suntharalingam K, et al. Interaction of metal complexes with G-quadruplex DNA. Angew Chem Int Ed Engl 2010;49(24):4020-34
   Google Scholar
• Thomas JA. Colorimetric detection of DNA structures with ruthenium chelates. WO2009050509; 2009
   Google Scholar
• Shi S, Zhao J, Yao T. New ruthenium polypyridine complex used as photoswitch of G-quadruplex DNA molecule comprising telomere G-quadruplex DNA of human beings. CN102464676A; 2010
   Google Scholar
• Yam VW-W, Yu C, Chan KH-Y, et al. Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes. US20080153103; 2008
   Google Scholar
• Hurley LH. Expanded porphyrin compositions for tumor inhibition. WO2004024091A2; 2004
   Google Scholar
• Dixon IM, Lopez F, Tejera AM, et al. A G-quadruplex ligand with 10000-fold selectivity over duplex DNA. J Am Chem Soc 2007;129(6):1502-3
   PubMed Web of Science ®Google Scholar
• Monchaud D, Teulade-Fichou MP. A hitchhiker's guide to G-quadruplex ligands. Org Biomol Chem 2008;6(4):627-36
   PubMed Web of Science ®Google Scholar
• Di Antonio M, Biffi G, Mariani A, et al. Selective RNA versus DNA G-quadruplex targeting by in situ click chemistry. Angew Chem Int Ed Engl 2012;51(44):11073-8
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46(1-3):3-26
   PubMed Web of Science ®Google Scholar
• Cosconati S, Rizzo A, Trotta R, et al. Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death. J Med Chem 2012;55(22):9785-92
   PubMed Web of Science ®Google Scholar
• Chan DS, Yang H, Kwan MH, et al. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer. Biochimie 2011;93(6):1055-64
   Google Scholar
• Ma DL, Shiu-Hin Chan D, Yang H, et al. Luminescent G-quadruplex probes. Curr Pharm Des 2012;18(14):2058-75
   Google Scholar
• Lu YJ, Yan SC, Chan FY, et al. Benzothiazole-substituted benzofuroquinolinium dye: a selective switch-on fluorescent probe for G-quadruplex. Chem Commun (Camb) 2011;47(17):4971-3
   Google Scholar
• Choo Y, Isalan M, Patel SD, et al. Modulating telomerase activity in a cell for treating cancer, comprises using an engineered zinc finger protein which binds telomeric nucleic acid, G-quadruplex nucleic acid and G-quartet nucleic acid. US2006166864A1; 2006
   Google Scholar
• Hardin CC, Brown BA II, Roberts JF, et al. Antibodies that selectively bind quadruplex nucleic acids. US6001657A; 1999
   Google Scholar
• Schaffitzel C, Berger I, Postberg J, et al. In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc Natl Acad Sci USA 2001;98(15):8572-7
   PubMed Web of Science ®Google Scholar
• Nadai M, Doria F, Di Antonio M, et al. Naphthalene diimide scaffolds with dual reversible and covalent interaction properties towards G-quadruplex. Biochimie 2011;93(8):1328-40
   Google Scholar
• Yuan L, Tian T, Chen Y, et al. Existence of G-quadruplex structures in promoter region of oncogenes confirmed by G-quadruplex DNA cross-linking strategy. Sci Rep 2013;3:1811
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Muller S, Yeoman JA, et al. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J Am Chem Soc 2008;130(47):15758-9
   PubMed Web of Science ®Google Scholar
• Vy Thi Le T, Han S, Chae J, et al. G-quadruplex binding ligands: from naturally occurring to rationally designed molecules. Curr Pharm Des 2012;18(14):1948-72
   Google Scholar